The rising awareness about the benefits of source plasma collection to save multiple patients in comparison to traditional whole blood collection is significantly transforming the overall blood collection industry, thereby driving the plasmapheresis market. In addition, significant evidence on the success rate of plasmapheresis in the immediate treatment of critically ill patients with many autoimmune diseases, hematologic, renal, and metabolic diseases; and favorable reimbursement policies for plasmapheresis procedure in these medical conditions are the major factors that have significantly impacted the development in plasmapheresis market.
Global Plasmapheresis Market is expected to reach USD 1,285.3 million by 2022, at a CAGR of 8.3% during the forecast period of 2017 to 2022. Following a comprehensive research on plasmapheresis and an in-depth analysis of the market scenario, the report carries out an impact analysis of the key industry drivers, restraints, and opportunities, listed in the market insights segment. Increasing incidence of autoimmune diseases, increasing demand for source plasma from biopharmaceutical companies, favorable reimbursement policies for plasmapheresis proceduresare the key market drivers covered in the report which will support the industry growth in the forecast period. However, high cost of plasmapheresis devices and procedures, lack of awareness about plasmapheresis procedures, and side effects associated with plasmapheresis procedures are restraining the adoption of this market to certain extent.
The report further gives an extensive outlook on the various end users of plasmapheresis. These end users include biopharmaceutical companies, hospitals & clinics, and other end users. The end users segment further briefly talks about the trends impacting the growth of these markets and the benefits involved with the use of plasmapheresis in these end users to improve overall treatment of autoimmune, hematologic, renal, and metabolic diseases.
???????????????????? ???????????????? ???????????????????????????? ???????????? ???????????? : https://bit.ly/3oFXQZj
An exhaustive analysis of the geographical scenario of the industry for the five major geographies: North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa is included in the geographical analysis section. These regions are further analyzed at a country level with the detailed qualitative and quantitative analysis. The geographical analysis provides detailed insights on the key trends of the industry in the listed regions & countries, identifying the demographic & economic impact, government & private investments, and regulatory scenario. The report identifies North America to be the largest market, followed by Europe. The geographical analysis section also comments on the key market players shaping the growth of the industry in the respective countries.
The key players operating in the global plasmapheresis market are Asahi Kasei Corporation (Japan), Terumo Corporation (Japan), Baxter International Inc. (U.S.), B. Braun Melsungen AG (Germany), Kawasumi Laboratories Inc. (Japan), Kaneka Corporation (Japan),    Haemonetics Corporation (U.S.), Fresenius SE & Co. KGaA (Germany), Shanghai Dahua Medical Apparatus Co., Ltd. (China), and Infomed SA (Switzerland).
Scope of Plasmapheresis Market Report:
Market by Product:
InstrumentsDisposablesMarket by Technology:
Membrane FiltrationCentrifugationMarket by Application:
Source Plasma CollectionTherapeutic PlasmapheresisMarket by End User:
Biopharmaceutical CompaniesHospitals &ClinicsOthersMarket by Geography:
North AmericaU.S.CanadaEuropeGermanyFranceU.K.ItalySpainRest of EuropeAsia-PacificJapanChinaIndiaAustraliaRest of Asia-PacificRest of WorldLatin AmericaMiddle-East & AfricaKey questions answered in Plasmapheresis Market report:
Rising demand for source plasma to drive the adoption of plasmapheresis
What impact does this have on the adoption of plasmapheresis for source plasma collection in comparison to therapeutic applications?Which are the high growth market segments in terms of product type, technology, application, end user, and regions/countries?Biopharmaceutical companies segment account for a larger proportion of all end users of plasmapheresis globally
What factors contribute to the large usage of plasmapheresis in biopharmaceutical industry?Conversely, which geographic segment is expected to experience the fastest growth for biopharmaceutical companies segment?The North American plasmapheresis market favors both larger and local manufacturers that compete in multiple segments
What are the top competitors in this market and what strategies do they employ to gain shares?What is driving growth and which market segments have the most potential for revenue expansion over the forecast period?What strategies should new companies looking to enter this market use to compete effectively?What are the major drivers, restrains, opportunities, and trends in the global plasmapheresismarket?Who are the major players in various countries and what share of the market do they hold?What are the geographical trends and high growth regions/ countries?